Biotech Approvals, Funding, and Deals
Kilder
- BioPharma Dive: Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
- Finance: Ionis’ rare neurology drug approved; Pfizer inks an ADC deal - Yahoo Finance
- Labiotech: How Evox Therapeutics is targeting CNS diseases with exosomes
- Finance: How Evox Therapeutics is targeting CNS diseases with exosomes｜Beyond Biotech - finance.biggo.com
- Finance: Per Lundin: Evox's exosome gene editing for Huntington's enters the clinic in late 2027 - finance.biggo.com
- Endpoints: US-China biotech NeuShen gets $80M to develop brain-health drugs
- GEN: Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases
- GEN: Micro-Bladder Model Demonstrates How Phage Therapy Could Help to Reduce Recurrent UTIs - Genetic Engineering and Biotechnology News
- Labiotech: Top biotech deals in August 2026
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.